Developing psoriasis didn’t exactly help with that internal dialogue. I began noticing symptoms when I was around 20, back in ...
Quick relief, cooling sensation, zero residue—what’s not to like?
Psoriasis risk in children is influenced by genetics and environmental triggers. Learn about hereditary factors, symptoms, and ways to reduce flare-ups.
Experts break down the key differences between two similar conditions.
Scientific advancements and new Anvisa regulations expand the debate on topical phytocannabinoids in the care of skin ...
Introduction: Skin diseases also affect the mindI'm so itchy that I can't sleep at night.I'm so self-conscious about my acne that I don't want to face people.My child's eczema won't get better, and ...
GLP-1 receptor agonists are increasingly being studied for potential dermatologic applications due to their anti-inflammatory ...
At Fall Clinical 2026, Joel Gelfand, MD, MSCE, reviewed GLP-1 candidacy, weight conversations, and an upcoming monotherapy ...
Arcutis Biotherapeutics reported past conference data on its ZORYVE portfolio, including Phase 2 INTEGUMENT-INFANT results in ...
Post hoc ICONIC phase 3 data show GLP-1 medications do not affect the efficacy, safety, or pharmacokinetics of icotrokinra in ...
Among patients with psoriatic disease and overweight or obesity, concomitant ixekizumab and tirzepatide therapy was ...
This is the Fall 2026 Membership Meeting of the Forum on Neuroscience and Nervous System Disorders. Members will receive an ...